Ferrosoferric Oxide: all 80 studies that test it
Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection FractionRecruitingNCT07634640Early Phase 1
- Nanozymes in EndodonticsEnrolling by invitationNCT07518901Phase 4
- Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma PatientsRecruitingNCT07461948Phase 3
- Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous DiseasesRecruitingNCT07452250Phase 2
- Enhanced MRI Imaging in Healthy Participants and Participants With EpilepsyRecruitingNCT06483061Phase 2
- Calculating Wall Shear Stress in Infant Pulmonary VeinsRecruitingNCT06440408Phase 1
- Virtual Histology of the Bladder Wall for Bladder Cancer StagingRecruitingNCT04369560Early Phase 1
- Early Antenatal Support for Iron Deficiency AnemiaRecruitingNCT04278651Phase 4
- Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical PatientRecruitingNCT04268849Phase 3
- IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine BleedingRecruitingNCT04205266Phase 4
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingNCT03893045Phase 3
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)RecruitingNCT03619850Phase 3
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemRecruitingNCT03270059Phase 2
- A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm TreatmentCompletedNCT06110494Phase 4Results posted
- A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in GlioblastomaActive, not recruitingNCT04900792Phase 1Results posted
- Placental Lesions in Fetal Growth RestrictionsCompletedNCT04839185Early Phase 1Results posted
- Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency AnemiaCompletedNCT04253626Phase 3Results posted
- Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device SupportTerminatedNCT04080908Phase 4Results posted
- Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With GlioblastomaTerminatedNCT03347617Phase 2Results posted
- Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain MetastasesTerminatedNCT03325166Phase 2Results posted
- Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart DiseaseCompletedNCT02752191Phase 4Results posted
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)CompletedNCT02694978Phase 3Results posted
- Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)CompletedNCT02499354Phase 2Results posted
- Active Preoperative Anemia Management in Patients Undergoing Cardiac SurgeryTerminatedNCT02189889Phase 1/2Results posted
- Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney CancersCompletedNCT02141490Phase 2Results posted
- Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic ResonanceCompletedNCT02006108Not applicableResults posted
- Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary StudyCompletedNCT01927887Not applicableResults posted
- Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node ImagingCompletedNCT01815333Not applicableResults posted
- MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentCompletedNCT01770353Phase 1Results posted
- Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With CancerCompletedNCT01542879Phase 1/2Results posted
- Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency AnemiaCompletedNCT01374919Not applicableResults posted
- Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRICompletedNCT01336803Phase 2Results posted
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01264679Phase 3Results posted
- Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisCompletedNCT01227616Phase 4Results posted
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney DiseaseTerminatedNCT01155388Phase 3Results posted
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01155375Phase 3Results posted
- Iron Indices and Intravenous Ferumoxytol: Time to Steady StateCompletedNCT01148745Phase 4Results posted
- A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency AnemiaCompletedNCT01114217Phase 3Results posted
- A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency AnemiaCompletedNCT01114204Phase 3Results posted
- A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency AnemiaCompletedNCT01114139Phase 3Results posted
- A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseCompletedNCT01052779Phase 2Results posted
- DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain TumorsCompletedNCT00978562Early Phase 1Results posted
- Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)CompletedNCT00707876Phase 2Results posted
- MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation TherapyCompletedNCT00660543Not applicableResults posted
- MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) InflammationTerminatedNCT00659776Phase 2Results posted
- Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain TumorsTerminatedNCT00659126Phase 2Results posted
- Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral MetastasesCompletedNCT00103038Not applicableResults posted
- Ferumoxytol-enhanced Magnetic Resonance ImagingTerminatedNCT06348524Phase 3
- Ferumoxytol-enhanced Imaging of OsteomyelitisCompletedNCT05959590Phase 1
- Predicting Stroke Risk in ICAD With Novel MRIWithdrawnNCT05515874Phase 4
- Novel Imaging Markers in SPMSCompletedNCT05357833Early Phase 1
- Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance ImagingCompletedNCT05045872Phase 1
- Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical PatientWithdrawnNCT03777514Not applicable
- Evaluation of Anti-biofilm Effects of Ferumoxytol (Feraheme) Using an in Situ Biofilm Demineralization ModelCompletedNCT03678012Early Phase 1
- Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in PregnancyCompletedNCT03657433Phase 3
- Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal CancerTerminatedNCT03280277Early Phase 1
- Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain TumorsWithdrawnNCT03234309Phase 2
- In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRIWithdrawnNCT03179449Early Phase 1
- Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance AngiographyCompletedNCT03173066Phase 1
- Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRICompletedNCT03084523Phase 1
- Ferumoxytol-enhanced Magnetic Resonance ImagingStatus unknownNCT02954510Phase 3
- Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal CancerWithdrawnNCT02857218Early Phase 1
- MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal CancerWithdrawnNCT02689401Phase 1
- Ferumoxytol-enhanced Imaging and Mapping in neuroAIDSCompletedNCT02678767Phase 2
- In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance ImagingCompletedNCT02511028Phase 1
- qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.CompletedNCT02466828Early Phase 1
- Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNSCompletedNCT02452216Early Phase 1
- Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With GlioblastomaCompletedNCT02359097Not applicable
- DEtection of Cellular Inflammation With FERumoxytol in the HEARTCompletedNCT02319278Phase 2/3
- Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal CancerCompletedNCT02253602Not applicable
- DCE MRI in Patients With Pancreatic CancerTerminatedNCT02070705Not applicable
- Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal CancerWithdrawnNCT01983371Not applicable
- Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis PatientsCompletedNCT01942460Phase 4
- Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRITerminatedNCT01895829Early Phase 1
- Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive DisordersCompletedNCT01665846Phase 1
- Ferumoxytol-Enhanced MRI in Adult/Pedi SarcomasWithdrawnNCT01663090Not applicable
- Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate CancerCompletedNCT01296139Phase 1
- Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using FerucarbotranCompletedNCT00886444Phase 2/3
- Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving ChemotherapyTerminatedNCT00769093Phase 1
- A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and WomenCompletedNCT00360425Phase 1